Milestones :: Perspectives :: Research
Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
European Medicines Agency
News & Press Releases
News: First COVID-19 vaccine approved for children aged 12 to 15 in EU (new)
CHMP, Last updated: 28/05/2021
EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 12 to 15. The vaccine is already approved for use in adults and adolescents aged 16 and above.
…The use of the Comirnaty vaccine in children from 12 to 15 will be the same as it is in people aged 16 and above. It is given as two injections in the muscles of the upper arm, given three weeks apart.
The effects of Comirnaty in children were investigated in 2,260 children aged 12 to 15 years. This study was carried out in accordance with Comirnaty’s paediatric investigation plan (PIP), which was agreed by EMA’s Paediatric Committee (PDCO)…
News: Insufficient data on use of inhaled corticosteroids to treat COVID-19 (new)
Last updated: 27/05/2021
European Centre for Disease Prevention and Control
SARS-CoV-2 variants dashboard
Press release 28 May 2021
The European Union outlines a €3 billion economic support package to a future democratic Belarus
Today, the European Commission is presenting to the Council its outline for a comprehensive plan of economic support to a future democratic Belarus. The plan, of up to €3 billion, reflects the European Union’s commitment to support the Belarusian people’s wishes for a peaceful democratic transition.
Press release 27 May 2021
Ukraine: EU allocates €25.4 million in humanitarian aid
As the conflict in eastern Ukraine enters its eighth year, the European Commission has announced €25.4 million in humanitarian aid to help people still suffering from the ongoing hostilities.
Press release 25 May 2021
EU increases humanitarian assistance for Palestine to over €34 million
Today, the EU has increased its humanitarian assistance to the most vulnerable people in Palestine by €8 million, taking the total to €34.4 million this year.